African scientists have developed a nanoscale drug delivery system to treat pericarditis, a drug-resistant and lethal ...
Researchers have unveiled new AI tools, from smartphone cough analysis to child-friendly screening systems, which could ...
A new test shows promising results for detecting latent tuberculosis infection in resource-limited settings. This is ...
Clinical trial results found that a new antibiotic candidate could shorten TB treatment from the standard 6 months to 8 weeks ...
With no cure or even treatment for HIV at that time, quickly raising awareness among the adult population through targeted ...
An expert panel calls the requirement for tuberculosis testing before prescribing IL-17 and IL-23 biologics for psoriasis an ...
News Medical on MSN
New AI tools offer hope for global TB elimination
Researchers have unveiled new AI tools, from smartphone cough analysis to child-friendly screening systems, which could transform how tuberculosis is detected, monitored and prevented.
News-Medical.Net on MSN
New clinical trial shows promise for shorter TB treatment
New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...
While the recognition of innovations such as point-of-care diagnostics is heartening, the bigger picture must not be lost ...
Despite strong national programmes, late diagnosis, treatment gaps, private-sector fragmentation, and poor adherence remain ...
allAfrica.com on MSN
Phase 2 clinical trial results show potential to shorten TB treatment time
New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel antibiotic candidate sorfequiline (TBAJ-876), a next-generation diarylquinoline, ...
A new TB drug, sorfequiline, shows promising results in a multinational trial, raising hopes for faster and simpler treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results